Sarah Carmody | Executive Director, Investor Relations and Corporate Communications |
Anna Protopapas | President and Chief Executive Officer |
Arvin Yang | Senior Vice President and Chief Medical Officer |
Timothy Lowinger | Chief Science and Technology Officer |
Brian DeSchuytner | Senior Vice President of Finance and Product Strategy |
Carla Poulson | Chief Human Resources Officer |
John Barrett | SVB Leerink LLC |
Konstantinos Aprilakis | Stifel |
Boris Peaker | Cowen |
Jessica Fye | JPMorgan |
Thomas Shrader | BTIG |
David Nierengarten | Wedbush Securities |
Good morning, and welcome to Mersana Therapeutics Fourth Quarter and Year End 2020 Conference Call. Currently, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the call. I would now like to turn the call over to Sarah Carmody, Executive Director, Investor Relations and Corporate Communications. Please proceed.